RESUMEN
PURPOSE: To evaluate the clinical outcome of early glottic cancer (GC) treated by primary radiotherapy (RT) with 6 MV photons. METHODS AND MATERIALS: We retrospectively reviewed the medical records of 695 consecutive patients with T1N0 and T2N0 GC treated between 1983 and 2005 by RT in our institution. Clinical outcome in terms of local control (LC), overall survival (OS) and cause- specific survival (CSS) rate were evaluated. RESULTS: The median follow-up time was 10.5 years. The 10-year actuarial LC rates were as follows: T1A, 91%; T1B, 87%; T2, 77%. The 10-year OS were as follows: T1, 74.2%; T2, 70.7%. The 10-year CSS were as follows: T1, 97.7%; T2, 97.1%.Poorly differentiated histology and tumor biologically effective dose<65 Gy15 were adverse factors in both LC of T1 and T2 disease. Involvement of anterior commissure was an adverse factor in both LC and CSS of T1 disease. Subglottic extension was associated with poor LC in T2 disease whereas hemoglobin <13.0 was associated with poor LC and CSS of T2 disease. CONCLUSION: Primary RT remains an option among the various standard treatments for early GC. Clinical treatment outcome by 6MV photons is similar and comparable to historic data of Cobalt-60 and 2 MV photons.
Asunto(s)
Fotones/uso terapéutico , Neoplasias de la Lengua/radioterapia , Adulto , Anciano , Anciano de 80 o más Años , Fraccionamiento de la Dosis de Radiación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Estudios Retrospectivos , Tasa de Supervivencia , Neoplasias de la Lengua/patología , Resultado del TratamientoRESUMEN
BACKGROUND: Incidence of breast cancer is rising in Asian countries, and breast cancer is the most common cancer among Asian women. However, there are few recent descriptive reports on the epidemiology of breast cancer among Eastern and Southeastern Asian populations. METHODS: We examined incidence trends for invasive breast cancer in women aged ≥20 years from 15 registries in Eastern (China, Japan, the Republic of Korea, Taiwan) and Southeastern Asia (the Philippines, Singapore, Thailand) for the period 1993-2002 mainly using data from Cancer Incidence in Five Continents, Volumes VIII and IX. We compared trends in annual incidence rates and age-specific incidence curves over a 10-year period. We also compared the incidence rates of Asian-Americans with the rates of their Asian counterparts. RESULTS: Breast cancer incidence rates increased gradually over time in all study populations. Rates were relatively high in Southeastern Asia and became progressively lower along a south-to-north gradient, with a fourfold geographic variation within the study populations. Age-specific incidence curves showed patterns that gradually changed according to incidence rates. Breast cancer incidence among Asian women living in the United States was 1.5-4 times higher than the corresponding incidence rate in the women's respective countries of origin. CONCLUSION: Breast cancer incidence is expected to continue to increase for the next 10 years in Asia and may approach rates reported among Asian-Americans. The number and mean age of breast cancer cases is expected to increase as the female Asian population ages, the prevalence of certain risk factors changes (early menarche, late menopause, low parity, late age at first live birth, and low prevalence of breastfeeding), and as Asian countries introduce mass screening programs.
Asunto(s)
Pueblo Asiatico , Neoplasias de la Mama/epidemiología , Adulto , Anciano , Asia Sudoriental/epidemiología , Asiático/estadística & datos numéricos , Neoplasias de la Mama/etiología , China/epidemiología , China/etnología , Femenino , Humanos , Incidencia , Japón/epidemiología , Japón/etnología , Tamizaje Masivo , Persona de Mediana Edad , Filipinas/epidemiología , Prevalencia , Sistema de Registros , República de Corea/epidemiología , República de Corea/etnología , Factores de Riesgo , Singapur/epidemiología , Singapur/etnología , Tailandia/epidemiología , Tailandia/etnología , Estados Unidos/epidemiologíaRESUMEN
Breast cancer risk is increasing in most Asian female populations, but little is known about the long-term mortality trend of the disease among these populations. We extracted data for Hong Kong (1979-2005), Japan (1963-2006), Korea (1985-2006), and Singapore (1963-2006) from the World Health Organization (WHO) mortality database and for Taiwan (1964-2007) from the Taiwan cancer registry. The annual age-standardized, truncated (to > or =20 years) breast cancer death rates for 11 age groups were estimated and joinpoint regression was applied to detect significant changes in breast cancer mortality. We also compared age-specific mortality rates for three calendar periods (1975-1984, 1985-1994, and 1995-2006). After 1990, breast cancer mortality tended to decrease slightly in Hong Kong and Singapore except for women aged 70+. In Taiwan and Japan, in contrast, breast cancer death rates increased throughout the entire study period. Before the 1990s, breast cancer death rates were almost the same in Taiwan and Japan; thereafter, up to 1996, they rose more steeply in Taiwan and then they began rising more rapidly in Japan than in Taiwan after 1996. The most rapid increases in breast cancer mortality, and for all age groups, were in Korea. Breast cancer mortality trends are expected to maintain the secular trend for the next decade mainly as the prevalence of risk factors changes and population ages in Japan, Korea, and Taiwan. Early detection and treatment improvement will continue to reduce the mortality rates in Hong Kong and Singapore as observed in Western countries.
Asunto(s)
Neoplasias de la Mama/mortalidad , Adulto , Factores de Edad , Anciano , Neoplasias de la Mama/prevención & control , Femenino , Hong Kong/epidemiología , Humanos , Japón/epidemiología , Corea (Geográfico)/epidemiología , Tamizaje Masivo , Persona de Mediana Edad , Singapur/epidemiología , Taiwán/epidemiología , Factores de TiempoRESUMEN
We analyzed the time trends of lung cancer by histological subtype in Hong Kong during 1991-2005, and examined how the time trends were influenced by the effects of birth cohort and calendar period of diagnosis. Cancer incidence data were obtained from Hong Kong Cancer Registry and population data from Census and Statistics Department. Age-standardized incidence rates were computed by the direct method using WHO 1966 standard population as reference. Period and cohort effects were assessed by using two separate Poisson regression models adjusting for age. From 1991 to 2005, the incidence rates in Hong Kong Chinese males decreased steadily. The decline in overall lung cancer incidence rates was limited primarily to the decrease in squamous cell carcinoma, which could be explained by the decreasing trend of cigarette smoking. Adenocarcinoma had been the most predominant histological subtype all along. The relatively horizontal trend of adenocarcinoma and the lack of cohort effect implied the important roles of gene-environment interaction and/or the use of low-tar and filter tip cigarettes. Our study suggests that different histological subtypes may represent different disease entities with perhaps some distinct risk factors. The hypotheses generated from this ecological study will need confirmation by subsequent analytic studies.
Asunto(s)
Neoplasias Pulmonares/epidemiología , Fumar/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/clasificación , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/etnología , Predicción , Hong Kong/epidemiología , Humanos , Incidencia , Neoplasias Pulmonares/clasificación , Neoplasias Pulmonares/etnología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Fumar/tendencias , Adulto JovenRESUMEN
BACKGROUND & OBJECTIVE: Although lung cancer is largely attributable to tobacco smoking, more than half of the female patients with adenocarcinoma are non-smokers in Hong Kong. This study dedicated to discover biomarkers for lung adenocarcinoma in non-smoking female patients with high-throughput proteinchip technology. METHODS: Protein profiles were generated from 29 specimens of primary lung cancers with matched adjacent non-cancer tissues using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS). RESULTS: Comparing the lung cancer and matched normal lung tissues from the non-smoking female patients, 52 proteins with differential expression were discovered, with a percentage of difference ranging from 60% to 213% for the top ten biomarkers. Comparing the lung cancer tissues from the patients without smoking history and those with smoking history, 84 proteins with differential expression were found. The area under receiver operating characteristic curve (AUC) for the top ten biomarkers ranged from 0.82 to 0.89. Comparing lung cancer tissues from female and male patients, 69 proteins with differential expression were found. The AUC for the top ten biomarkers was ranged from 0.81 to 0.86. CONCLUSION: Using SELDI-TOF-MS, the biomarker candidates that are highly associated with non-smoking female patients with lung adenocarcinoma were filtered.